 Connection
Peter Dahlberg to Tissue Donors
This is a "connection" page, showing publications Peter Dahlberg has written about Tissue Donors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.121 |
|
|
|
-
Herrington CS, Prekker ME, Arrington AK, Susanto D, Baltzell JW, Studenski LL, Radosevich DM, Kelly RF, Shumway SJ, Hertz MI, Bittner HB, Dahlberg PS. A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation. Clin Transplant. 2011 Jan-Feb; 25(1):90-6.
Score: 0.063
-
Whitson BA, Nath DS, Johnson AC, Walker AR, Prekker ME, Radosevich DM, Herrington CS, Dahlberg PS. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2006 Jan; 131(1):73-80.
Score: 0.046
-
Nath DS, Walter AR, Johnson AC, Radosevich DM, Prekker ME, Herrington CS, Dahlberg PS, Kelly RF. Does Perfadex affect outcomes in clinical lung transplantation? J Heart Lung Transplant. 2005 Dec; 24(12):2243-8.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|